US 6,335,360 B1 · Tripeptidyl peptidase inhibitors

Abstract

The invention is relative to a compound of formula (I) and its use as an inhibitor of the CCK-inactivating peptidase tripeptidyl peptidase (TPP II). The invention concerns in particular the treatment of eating disorder, obesity, psychotic syndrome and associated psychiatric disorders. It concerns also the cosmetic use of a compound (I) in particular to aid slimming.

Claims0

Dependent claims

Claims aren’t available for this document.

Facts

Application

09/581,830Filed 18 Sep 2000

Granted

1 Jan 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification6 codes

C07D 209/42
With hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon…
A61P 3/04
Drugs for disorders of the metabolism: anorexiants; Antiobesity agents
A61P 25/18
Drugs for disorders of the nervous system: antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
A61P 43/00
Drugs for specific purposes, not provided for in groups a61p1/00-a61p41/00

Tripeptidyl peptidase inhibitors

Life of this patent

Abstract

Claims0

Tripeptidyl peptidase inhibitors

Life of this patent

Abstract

Claims0